T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 6780-6786

  Kobie, James J ^a   Shah, Pranav R ^a   Yang, Li ^a   Rebhahn, Jonathan A ^a   Fowell, Deborah J ^a   Mosmann, Tim R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ADENOSINE PHOSPHATE; CD3 ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD28;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; IMMUNITY; INFLAMMATORY CELL; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; REGULATORY T LYMPHOCYTE; TARGET CELL; TH1 CELL; TH2 CELL;

EID: 33750832563     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.6780     Document Type: Article

References (59)

1. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α. J. Immunol. 157: 798-805.
2. Boivin, G. P., B. A. O'Toole, I. E. Orsmby, R. J. Diebold, M. J. Eis, T. Doetschman, and A. B. Kier. 1995. Onset and progression of pathological lesions in transforming growth factor-β 1-deficient mice. Am. J. Pathol. 146: 276-288.
3. 2A receptors in down-regulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes Infect. 5: 515-526.
4. 2A receptors in human monocytic THP-1 cells. J. Immunol. 167: 4026-4032.
5. Panther, E., M. Idzko, Y. Herouy, H. Rheinen, P. J. Gebicke-Haerter, U. Mrowietz, S. Dichmann, and J. Norgauer. 2001. Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15: 1963-1970.
6. Cronstein, B. N., R. I. Levin, J. Belanoff, G. Weissmann, and R. Hirschhorn. 1986. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J. Clin. Invest. 78: 760-770.
7. 2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 20: 187-189.
8. 2A adenosine receptor in vivo. J. Immunol. 173: 21-24.
9. Gomez, G., and M. V. Sitkovsky. 2003. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102: 4472-4478.
10. 2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129: 26-33.
11. Buckley, R. H. 2004. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22: 625-655.
12. Hershfield, M. S. 2005. New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur. J. Immunol. 35: 25-30.
13. Huang, S., S. Apasov, M. Koshiba, and M. Sitkovsky. 1997. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610.
14. 2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105: 4707-4714.
15. + T cells. J. Immunol. 174: 1073-1080.
16. 125I]iodophenyl)ethylamino) adenosine, Mol. Pharmacol. 47: 307-313.
17. Bruns, R. F., J. W. Daly, and S. H. Snyder. 1980. Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H] phenylxanthine. Proc. Natl. Acad. Sci. USA 77: 5547-5551.
18. 2B receptors. J. Exp. Med. 198: 783-796.
19. Deussen, A., B. Bading, M. Kelm, and J. Schrader. 1993. Formation and salvage of adenosine by macrovascular endothelial cells. Am. J. Physiol. 264: H692-H700.
20. Thompson, L. F., J. M. Ruedi, M. G. Low, and L. T. Clement. 1987. Distribution of ecto-5′-nucleotidase on subsets of human T and B lymphocytes as detected by indirect immunofluorescence using goat antibodies. J. Immunol. 139: 4042-4048.
21. Thompson, L. F., J. M. Ruedi, A. Glass, M. G. Low, and A. H. Lucas. 1989. Antibodies to 5′-nucleotidase (CD73), a glycosyl-phosphatidylinositol- anchored protein, cause human peripheral blood T cells to proliferate. J. Immunol. 143: 1815-1821.
22. Yang, L., J. J. Kobie, and T. R. Mosmann. 2005. CD73 and Ly-6A/E distinguish in vivo primed but uncommitted mouse CD4 T cells from type 1 or type 2 effector cells. J. Immunol. 175: 6458-6464.
23. Zimmermann, H. 1992. 5′-Nucleotidase: molecular structure and functional aspects. Biochem. J. 285: 345-365.
24. Sad, S., and T. R. Mosmann. 1994. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153: 3514-3522.
25. Iezzi, G., D. Scheidegger, and A. Lanzavecchia. 2001. Migration and function of antigen-primed nonpolarized T lymphocytes in vivo. J. Exp. Med. 193: 987-993.
26. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
27. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
28. + regulatory T cells. Nat. Immunol. 4: 330-336.
29. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
30. von Boehmer, H. 2005. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6: 338-344.
31. Glimcher, L. H., T. Hamano, R. Asofsky, D. H. Sachs, M. Pierres, L. E. Samelson, S. O. Sharrow, and W. E. Paul. 1983. IA mutant functional antigen-presenting cell lines. J Immunol. 130: 2287-2294.
32. Gazagne, A., E. Claret, J. Wijdenes, H. Yssel, F. Bousquet, E. Levy, P. Vielh, F. Scotte, T. L. Goupil, W. H. Fridman, and E. Tartour. 2003. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J. Immunol. Methods 283: 91-98.
33. Weiner, H. L. 2001. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182: 207-214.
34. Wang, X., and T. Mosmann. 2001. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or Interferon (IFN)-γ, and can subsequently differentiate into IL-4- or IFN-γ-secreting cells. J. Exp. Med. 194: 1069-1080.
35. Yang, L., and T. Mosmann. 2004. Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions. Eur. J. Immunol. 34: 1617-1626.
36. 2A purinergic receptor mediated signaling in murine T cells. J. Biol. Chem. 272: 25881-25889.
37. 1 adenosine receptors. Brain Res. 368: 394-398.
38. Dwyer, K. M., S. C. Robson, H. H. Nandurkar, D. J. Campbell, H. Gock, L. J. Murray-Segal, N. Fisicaro, T. B. Mysore, E. Kaczmarek, P. J. Cowan, and A. J. d'Apice. 2004. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J. Clin. Invest. 113: 1440-1446.
39. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10: 1969-1980.
40. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
41. + regulatory T cell activity. J. Immunol. 175: 7274-7280.
42. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
43. 2B receptor activation. J. Exp. Med. 188: 1433-1443.
44. Narravula, S., P. F. Lennon, B. U. Mueller, and S. P. Colgan. 2000. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J Immunol. 165: 5262-5268.
45. high T cells in inflammatory bowel disease. Gastroenterology 128: 1868-1878.
46. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schon, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104.
47. + regulatory T cell proliferation. J. Exp. Med. 202: 919-929.
48. + regulatory T cells is antigen-specific and requires IL-10 and TGF-β. J Immunol. 175: 4283-4291.
49. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
50. + regulatory T cells is not essential for suppression of intestinal inflammation. Eur. J. Immunol. 35: 2886-2895.
51. + T cells. J. Immunol. 173: 6526-6531.
52. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100: 10878-10883.
53. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
54. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
55. + T cells restrain the maturation and antigen-presenting function of dendritic cells. J. Immunol. 172: 4676-4680.
56. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30: 1538-1543.
57. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92.
58. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
59. Divekar, A. A., D. M. Zaiss, F. E. Lee, D. Liu, D. J. Topham, A. J. Sijts, and T. R. Mosmann. 2006. Protein vaccines induce uncommitted IL-2-secreting human and mouse CD4 T cells, whereas infections induce more IFN-γ-secreting cells. J. Immunol. 176: 1465-1473.